With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

The KG2032 CAR T cells displayed strong and specific anti-AML effects in vitro with cell culture experiments ... Engineered cord blood-derived CAR natural killer (NK) cells showed similar results.

Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells.

Bharat currently has five products in its personalized medicine pipeline—two in cell culture and three in the ... working on a range of CAR-T cell, CAR-NK cell and off-the-shelf gene therapies ...

The KG2032 CAR T cells displayed strong and specific anti-AML effects in vitro with cell culture experiments ... cord blood-derived CAR natural killer (NK) cells showed similar results.

Cellistic has launched the Echo-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target ...